卵巢癌初始治疗中手术与化疗碎片化与总生存期的关联
该研究基于美国国家癌症数据库2004-2016年36,300例II-IV期上皮性卵巢癌患者,分析初次肿瘤细胞减灭术(PDS)与辅助化疗(AC)在不同医院进行的碎片化对总生存期(OS)的影响。倾向评分加权后,碎片化化疗与死亡率降低相关(HR 0.95,95%CI 0.92-0.97),但碎片化与30天化疗延迟风险增加15%相关(aRR 1.15,95%CI 1.09-1.22)。结论认为PDS与AC碎片化对长期生存无不良影响,但同一机构距离≥50英里的患者生存最差。
要点
- 碎片化化疗与死亡率降低相关(HR 0.95,95%CI 0.92-0.97)。
- 碎片化与30天化疗延迟风险增加15%相关(aRR 1.15,95%CI 1.09-1.22)。
- PDS与AC同一机构且距离≥50英里者总生存期最差。
核心结论
- PDS与AC碎片化对长期生存无不良影响。
- 碎片化化疗与死亡率降低相关(HR 0.95,95%CI 0.92-0.97)。
- 同一机构接受PDS和AC且距离≥50英里的患者生存最差。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库2004-2016年数据。
- 纳入36,300例II-IV期上皮性卵巢癌患者,均接受PDS后AC。
- 碎片化定义为AC在不同于PDS的机构进行。
- 采用倾向评分加权和比例风险模型分析。
主要发现
- 13,347例(36.8%)患者接受碎片化治疗。
- 碎片化与30天化疗延迟风险增加15%相关(aRR 1.15,95%CI 1.09-1.22)。
- 倾向评分加权分析显示碎片化化疗者死亡率降低(HR 0.95,95%CI 0.92-0.97)。
- 敏感性分析提示碎片化与大都市居民生存改善相关。
- 分层分析显示PDS和AC同一机构且距离≥50英里的患者OS最差。
关键数值与推荐
- 碎片化相关患者因素:年龄较大、收入较高、PDS旅行距离较长(P<0.05)。
- 碎片化相关医院因素:PDS在社区中心或年手术量较低的机构进行(P<0.05)。
临床怎么用
- 卵巢癌初始治疗中PDS与AC在不同机构进行未显示生存劣势。
- 应关注化疗延迟风险,尤其碎片化治疗时。
- 对于需长途旅行(≥50英里)在同一机构完成PDS和AC的患者,需评估生存劣势。
局限性
- 回顾性研究,可能存在未测量混杂因素。
- 碎片化定义仅基于AC机构与PDS机构不同,未考虑其他治疗环节。
- 数据库可能未涵盖所有相关变量(如化疗方案细节)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fragmentation occurs when a patient receives care at more than one hospital, and the long-term effects in ovarian cancer are unknown. We examined the association between fragmentation of primary debulking surgery (PDS) and adjuvant chemotherapy (AC) and overall survival (OS). METHODS: The National Cancer Database was used to identify women with stage II-IV epithelial ovarian cancer between 2004 and 2016 who underwent PDS followed by AC. Fragmentation was defined as receipt of AC at a different institution than where PDS was performed. After propensity score weighting, proportional hazard models were developed to estimate the association between fragmented care and OS. RESULTS: Of the 36,300 patients identified, 13,347 (36.8%) had fragmented care. Patient factors associated with fragmentation included older age, higher income, and longer travel distance for PDS; hospital factors included PDS performed at a community center or a facility with lower annual surgical volume (P < 0.05, all). Fragmentation was associated with a 15% risk of 30-day delay to AC (aRR 1.15, 95% CI 1.09-1.22). In a propensity scoring weighted analysis, mortality was reduced when AC was fragmented (HR 0.95, 95% CI 0.92-0.97). Sensitivity analyses indicated fragmentation was associated with improved survival in metropolitan residents. Stratified analyses indicated patients who traveled 50 miles or more with PDS and AC at the same institution had the worst OS. CONCLUSION: Fragmentation of PDS and AC has no adverse effects on long-term survival. Survival outcomes were worst for those who received care at the same institution 50 miles or more away.
引用
- Cham S, Huang Y, Melamed A, et al. Fragmentation of surgery and chemotherapy in the initial phase of ovarian cancer care and its association with overall survival. Gynecol Oncol. 2021. PMID: 33965245. doi:10.1016/j.ygyno.2021.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。